Clinical Trial Update: Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sorafenib in patients with soft tissue sarcomas, including metastatic and recurrent subtypes; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Osteosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Osteosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2014-03-17